非骨水泥部分膝关节植入物市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024年，全球非骨水泥型部分膝关节植入物市场规模达7.897亿美元，预计年复合成长率为5.5%，到2034年将达到13亿美元。推动这一增长的关键因素包括：感染率上升导致膝关节翻修手术增多；骨关节炎和类风湿性关节炎盛行率上升；以及人们对微创手术的偏好增加。老年骨关节炎患者数量的增加，以及对更有效、微创手术方案的需求，是该市场的关键驱动因素。非骨水泥型部分膝关节植入物用于单髁膝关节置换术(UKA)，仅替换膝关节的患侧，从而保留更多天然骨骼和韧带。

这些植入物无需骨水泥，而是以生物固定取代。这种方法促进了植入物周围骨组织的自然生长，从而使植入物与骨骼之间的结合更加牢固持久。无需骨水泥不仅可以最大限度地降低植入物随时间推移鬆动的风险，还能降低骨水泥相关感染和发炎等併发症的可能性。此外，生物固定可以增强植入物的整体稳定性，从而可能延长其使用寿命并改善患者的长期预后。因此，非骨水泥植入物具有更自然的癒合过程，并且可能需要更少的修復，使其成为骨科手术中越来越受欢迎的选择。

固定轴承植入物市场预计将以 5.3% 的复合年增长率成长，到 2034 年达到 8.762 亿美元。与活动轴承系统相比，这些植入物机械结构更简单，且不易发生故障，因此更受外科医师的欢迎。对于低需求患者，它们十年的长期存活率超过 90%。此外，活动轴承系统通常更昂贵、更复杂，这限制了它们的接受度和广泛应用。因此，在许多情况下，固定轴承系统是首选，这加速了它们的普及，并巩固了其市场主导地位。

预计钛基植入物市场将达到5.4%的成长率，到2034年将达到7.818亿美元。钛的生物相容性使其成为非骨水泥植入物的理想选择，因为它能够促进骨整合，而骨整合对于此类植入物的成功至关重要。与钴铬合金相比，钛植入物与骨组织的黏附性更强，抗鬆动性更强，从而提高了植入物的稳定性和使用寿命。钛合金的轻量特性加上其强度，使其特别适合年轻、活跃且术后需要更大活动能力的患者。此外，钛合金也是金属敏感患者的理想选择，这进一步推动了个人化膝关节置换术的需求。

2024年，美国非骨水泥部分膝关节植入物市场规模达3.537亿美元。美国人口老化是全球成长最快的群体之一，这推动了膝关节置换手术的需求不断增长。骨关节炎，尤其是内侧单髁骨关节炎，是推动部分膝关节置换需求的主要疾病之一。此外，由于麻醉时间短、失血量少、恢復更快等优势，美国的门诊骨科手术数量正在增加，尤其是在门诊手术中心。此外，美国拥有完善的报销体系，私人保险公司和联邦医疗保险（Medicare）越来越认识到，对于合适的患者，部分膝关节置换比全膝关节置换更具成本效益。

全球非骨水泥型部分膝关节植入物市场的领导者包括史赛克 (Stryker)、Medacta、Amplitude Surgical、施乐辉 (Smith+Nephew)、Waldemar Link、GRUPPO BIOIMPIANTI、ZIMMER BIOMET、Lepine、Just Medical 和 Medacta。为了巩固市场地位，非骨水泥型部分膝关节植入物产业的企业正专注于多种策略。他们投资于持续创新，以改善植入物的设计和功能，例如增强植入物的生物相容性和骨整合性能。此外，他们还与医疗服务提供者、诊所和医院建立合作伙伴关係，以扩大产品覆盖范围并确保更高的采用率。此外，企业也注重区域扩张，尤其是在骨科手术需求日益增长的新兴市场。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 感染率上升导致膝关节翻修手术增多
    • 骨关节炎和类风湿性关节炎盛行率不断上升
    • 微创手术日益受到青睐
    • 非骨水泥固定方法的技术进步
  • 产业陷阱与挑战
    • 非骨水泥型膝关节植入物成本高
• 成长潜力分析
• 监管格局
• 技术格局
• 报销场景
• 差距分析
• 波特的分析
• PESTEL分析
• 未来市场趋势

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按植入物类型，2021 - 2034 年

• 主要趋势
• 固定轴承植入物
• 活动轴承植入物
• 内侧枢轴植入物
• 其他植入物类型

第六章：市场估计与预测：按材料，2021 - 2034 年

• 主要趋势
• 钛基
• 钴铬合金
• 聚乙烯成分
• 其他材料

第七章：市场估计与预测：依最终用途，2021 - 2034 年

• 主要趋势
• 医院
• 骨科中心
• 其他最终用途

第八章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第九章：公司简介

• amplitude SURGICAL
• GRUPPO BIOIMPIANTI
• JUST MEDICAL
• lepine
• Medacta
• Smith+Nephew
• Stryker
• Waldemar Link
• ZIMMER BIOMET

The Global Cementless Partial Knee Implants Market was valued at USD 789.7 million in 2024 and is estimated to grow at a CAGR of 5.5% to reach USD 1.3 billion by 2034. The key factors contributing to this growth include the rising infection rates leading to an increase in knee revision surgeries, the growing prevalence of osteoarthritis and rheumatoid arthritis, and a greater preference for minimally invasive procedures. The increasing number of elderly individuals with osteoarthritis and the demand for more effective, less invasive surgical options are crucial drivers for this market. Cementless partial knee implants, used in unicompartmental knee arthroplasty (UKA) procedures, only replace the affected portion of the knee joint, preserving more natural bone and ligaments.

These implants eliminate the need for bone cement, facilitating biological fixation instead. This method encourages the natural growth of bone tissue around the implant, leading to stronger and more durable integration between the implant and the bone. The absence of bone cement not only minimizes the risk of implant loosening over time but also reduces the likelihood of complications such as cement-related infections and inflammation. Moreover, biological fixation can enhance the overall stability of the implant, potentially extending its lifespan and improving long-term patient outcomes. As a result, cementless implants offer a more natural healing process and may require fewer revisions, making them an increasingly preferred option in orthopedic procedures.

Fixed-bearing implants segment is expected to grow at a CAGR of 5.3% to reach USD 876.2 million by 2034. These implants are mechanically simpler and less prone to failure than mobile-bearing systems, making them more popular among surgeons. They offer long-term survival rates of over 90% at ten years in low-demand patients. Additionally, mobile-bearing systems are typically more expensive and complex, which limits their acceptance and widespread use. As a result, fixed-bearing systems are the preferred choice in many cases, accelerating their adoption and contributing to their market dominance.

The titanium-based segment is anticipated to experience a growth rate of 5.4%, reaching USD 781.8 million by 2034. Titanium's biocompatibility makes it ideal for cementless implants, as it promotes osseointegration, which is crucial for the success of these devices. Titanium implants offer better adhesion to bone tissue and greater resistance to loosening compared to cobalt-chromium alloys, enhancing their stability and lifespan. The lightweight nature of titanium alloys, combined with their strength, makes them particularly suitable for younger, more active patients who require greater mobility post-surgery. Additionally, titanium is ideal for individuals with metal sensitivities, further driving demand for personalized knee arthroplasty.

U.S. Cementless Partial Knee Implants Market was valued at USD 353.7 million in 2024. The aging population in the U.S. is one of the fastest-growing demographics globally, contributing to the rising demand for knee replacement procedures. Osteoarthritis, especially medial unicompartmental osteoarthritis, is one of the primary conditions driving the need for partial knee replacements. Additionally, outpatient orthopedic surgeries are on the rise in the U.S., particularly in ambulatory surgical centers, due to the advantages of shorter anesthesia times, minimal blood loss, and quicker recovery. Moreover, the U.S. benefits from a robust reimbursement system, with both private insurers and Medicare increasingly recognizing the cost-effectiveness of partial knee replacements over total knee replacements for suitable patients.

The leading players in the Global Cementless Partial Knee Implants Market include Stryker, Medacta, Amplitude Surgical, Smith+Nephew, Waldemar Link, GRUPPO BIOIMPIANTI, ZIMMER BIOMET, Lepine, Just Medical, and Medacta. To strengthen their market presence, companies in the cementless partial knee implants industry are focusing on several strategies. They are investing in continuous innovation to improve implant designs and functionality, such as enhancing the biocompatibility and osseointegration properties of the implants. Partnerships with healthcare providers, clinics, and hospitals are also being forged to expand product reach and ensure higher adoption rates. Additionally, companies are focusing on regional expansion, particularly in emerging markets where the demand for orthopedic procedures is increasing.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising infection rates contributing to the rise in knee revisions
    • 3.2.1.2 Increasing prevalence of osteoarthritis and rheumatoid arthritis
    • 3.2.1.3 Growing preference for minimally invasive procedures
    • 3.2.1.4 Technological advancements in cementless fixation methods
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with cementless knee implants
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Reimbursement scenario
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Future market trends

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Implant Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Fixed-bearing implants
• 5.3 Mobile-bearing implants
• 5.4 Medial pivot implants
• 5.5 Other implant types

Chapter 6 Market Estimates and Forecast, By Material, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Titanium-based
• 6.3 Cobalt-chromium alloys
• 6.4 Polyethylene components
• 6.5 Other materials

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Orthopedic centres
• 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 amplitude SURGICAL
• 9.2 GRUPPO BIOIMPIANTI
• 9.3 JUST MEDICAL
• 9.4 lepine
• 9.5 Medacta
• 9.6 Smith+Nephew
• 9.7 Stryker
• 9.8 Waldemar Link
• 9.9 ZIMMER BIOMET